Analyst Rating Changes — Upgrades, Downgrades & Price Targets

35054 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

WhenStockChange FirmAnalyst RatingPrice Target
Sep 03
13:55 UTC
RARE
Ultragenyx Pharmaceutical
◎ Target Canaccord Genuity Group Whitney Ijem ★★☆☆☆ #2345 Buy $83.00→ $37.00-55.4%
Sep 03
13:55 UTC
NTAP
NetApp
◎ Target Susquehanna Mehdi Hosseini ★★★★☆ #674 Neutral $185.00→ $195.00+5.4%
Sep 03
13:55 UTC
NTAP
NetApp
◎ Target Wedbush Matt Bryson ★★★☆☆ #992 Neutral $150.00→ $170.00+13.3%
Sep 03
13:55 UTC
ILMN
Illumina
◎ Target Argus Jasper Hellweg ★★★☆☆ #2161 Buy $180.00→ $235.00+30.6%
Sep 03
13:55 UTC
HPE
Hewlett Packard Enterprise
◎ Target Barclays Tim Long ★★★☆☆ #1852 Overweight $67.00→ $79.00+17.9%
Sep 03
13:55 UTC
GOLD
Gold.com
◎ Target Canaccord Genuity Group Brian McNamara ★★★☆☆ #2189 Buy $70.00→ $65.00-7.1%
Sep 03
13:55 UTC
DRTS
Alpha Tau Medical
◎ Target Barclays Lukas Shumway not yet tracked Overweight $17.00→ $30.00+76.5%
Sep 03
13:55 UTC
AXON
Axon Enterprise
◎ Target Argus John Staszak ★★★☆☆ #1602 Buy $460.00→ $600.00+30.4%
Sep 03
13:55 UTC
ADBE
Adobe
◎ Target Barclays Saket Kalia ★★★☆☆ #1459 Equal Weight $250.00→ $295.00+18.0%
Sep 03
13:55 UTC
RARE
Ultragenyx Pharmaceutical
↓ Downgrade William Blair firm only Outperform→ Market Perform
Sep 03
13:55 UTC
RARE
Ultragenyx Pharmaceutical
↓ Downgrade Evercore firm only Outperform→ Inline $16.00
Sep 03
13:55 UTC
GGAL
Grupo Financiero Galicia
↓ Downgrade Itau BBA Securities firm only Outperform→ Market Perform
Sep 03
13:55 UTC
FNLPF
Fresnillo
↓ Downgrade Barclays firm only Equal Weight→ Underweight
Sep 03
13:55 UTC
CCHGY
Coca-Cola HBC
↓ Downgrade Investec firm only Hold
Sep 03
13:55 UTC
BMA
Macro Bank
↓ Downgrade Itau BBA Securities firm only Outperform→ Market Perform
Sep 03
13:55 UTC
AGX
Argan
↑ Upgrade Lake Street Capital Robert Brown ★★★☆☆ #1509 Hold→ Buy $600.00
Sep 03
12:55 UTC
WOOF
Petco Health and Wellness
◎ Target Robert W. Baird Peter Benedict ★★★★☆ #600 Neutral $3.00→ $3.25+8.3%
Sep 03
12:55 UTC
TEAM
Atlassian
◎ Target BTIG Research Allan Verkhovski ★★★☆☆ #1502 Buy $180.00→ $230.00+27.8%
Sep 03
12:55 UTC
SNOW
Snowflake
◎ Target Canaccord Genuity Group Kingsley Crane ★★★☆☆ #995 Buy $325.00→ $450.00+38.5%
Sep 03
12:55 UTC
SNOW
Snowflake
◎ Target Needham & Company LLC Mike Cikos ★★★★☆ #547 Buy $330.00→ $450.00+36.4%
Sep 03
12:55 UTC
SNOW
Snowflake
◎ Target Citizens Jmp Patrick Walravens ★★★★★ #215 Market Outperform $408.00→ $488.00+19.6%
Sep 03
12:55 UTC
SNOW
Snowflake
◎ Target Monness Crespi & Hardt Brian White ★★★☆☆ #1841 Buy $380.00→ $450.00+18.4%
Sep 03
12:55 UTC
SNOW
Snowflake
◎ Target BTIG Research Gray Powell ★★★☆☆ #1173 Buy $340.00→ $424.00+24.7%
Sep 03
12:55 UTC
RARE
Ultragenyx Pharmaceutical
◎ Target HC Wainwright Raghuram Selvaraju not yet tracked Buy $50.00→ $25.00-50.0%
Sep 03
12:55 UTC
RARE
Ultragenyx Pharmaceutical
◎ Target Cantor Fitzgerald Kristen Kluska ★★★☆☆ #1529 Overweight $103.00→ $33.00-68.0%
Sep 03
12:55 UTC
PATH
UiPath
◎ Target Needham & Company LLC Scott Berg ★★★☆☆ #1354 Buy $15.00→ $22.00+46.7%
Sep 03
12:55 UTC
NTSK
Netskope
◎ Target Robert W. Baird Shrenik Kothari ★★★☆☆ #1232 Outperform $18.00→ $20.00+11.1%
Sep 03
12:55 UTC
NTSK
Netskope
◎ Target BTIG Research Gray Powell ★★★☆☆ #1173 Buy $17.00→ $18.00+5.9%
Sep 03
12:55 UTC
NTSK
Netskope
◎ Target Rosenblatt Securities Catharine Trebnick ★★☆☆☆ #2284 Buy $18.00→ $19.00+5.6%
Sep 03
12:55 UTC
MGNI
Magnite
◎ Target Needham & Company LLC Laura Martin ★★★☆☆ #2136 Buy $25.00→ $30.00+20.0%
Sep 03
12:55 UTC
JILL
J.Jill
◎ Target Telsey Advisory Group Dana Telsey ★★★☆☆ #2122 Market Perform $14.00→ $18.00+28.6%
Sep 03
12:55 UTC
GIII
G-III Apparel Group
◎ Target Telsey Advisory Group Dana Telsey ★★★☆☆ #2122 Market Perform $38.00→ $32.00-15.8%
Sep 03
12:55 UTC
DKNG
DraftKings
◎ Target Sanford C. Bernstein Ian Moore not yet tracked Outperform $27.00→ $29.00+7.4%
Sep 03
12:55 UTC
AVGO
Broadcom
◎ Target BMO Capital Markets Harsh Kumar ★★★★☆ #516 Outperform $455.00→ $575.00+26.4%
Sep 03
12:55 UTC
AVGO
Broadcom
◎ Target Rosenblatt Securities Sajal Dogra not yet tracked Buy $500.00→ $600.00+20.0%
Sep 03
12:55 UTC
AVGO
Broadcom
◎ Target Cantor Fitzgerald C.J. Muse not yet tracked Overweight $525.00→ $600.00+14.3%
Sep 03
12:55 UTC
AIN
Albany International
◎ Target Robert W. Baird Peter Arment ★★★★★ #152 Neutral $64.00→ $75.00+17.2%
Sep 03
12:55 UTC
ZTO
ZTO Express (Cayman)
↓ Downgrade JPMorgan Chase & Co. David Chen not yet tracked Overweight→ Neutral $22.00
Sep 03
12:55 UTC
SON
Sonoco Products
↓ Downgrade Bank of America George Staphos ★★★☆☆ #1866 Buy→ Neutral $69.00→ $60.00-13.0%
Sep 03
12:55 UTC
RARE
Ultragenyx Pharmaceutical
↓ Downgrade Evercore firm only Outperform→ In-Line $16.00
Sep 03
12:55 UTC
RARE
Ultragenyx Pharmaceutical
↓ Downgrade Robert W. Baird Joel Beatty ★☆☆☆☆ #2903 Outperform→ Neutral $40.00→ $16.00-60.0%
Sep 03
12:55 UTC
RARE
Ultragenyx Pharmaceutical
↓ Downgrade JPMorgan Chase & Co. Anupam Rama ★★★☆☆ #1979 Overweight→ Neutral $36.00
Sep 03
12:55 UTC
RARE
Ultragenyx Pharmaceutical
↓ Downgrade Wells Fargo & Company Michael Turrin ★★★☆☆ #1204 Overweight→ Equal Weight $18.00
Sep 03
12:55 UTC
PCG
Pacific Gas & Electric
↓ Downgrade Truist Financial Richard Sunderland ★★★☆☆ #1473 Buy→ Hold $17.00
Sep 03
12:55 UTC
MRNA
Moderna
↓ Downgrade Rothschild & Co Redburn Simon Baker not yet tracked Neutral→ Sell $40.00→ $81.00+102.5%
Sep 03
12:55 UTC
FLNC
Fluence Energy
↓ Downgrade Barclays Christine Cho ★★★★★ #294 Equal Weight→ Underweight $10.00
Sep 03
12:55 UTC
CVSA
Adtalem Global Education
↓ Downgrade Truist Financial Jasper Bibb ★★☆☆☆ #2274 Buy→ Hold $140.00
Sep 03
12:55 UTC
NVST
Envista
↑ Upgrade JPMorgan Chase & Co. Lilia-Celine Lozada not yet tracked Neutral→ Overweight $32.00
Sep 03
12:55 UTC
CPRT
Copart
↑ Upgrade JPMorgan Chase & Co. firm only Neutral→ Overweight $40.00
Sep 03
11:55 UTC
ALMS
Alumis
↓ Downgrade Guggenheim Yatin Suneja ★★★☆☆ #1077 Buy→ Neutral
🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.
A free account unlocks the full daily feed.
‹ Prev 110 / 702 Next ›

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.